Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysis

Lin Yang, Shidan Wang, David E. Gerber, Yunyun Zhou, Feng Xu, Jiewei Liu, Hao Liang, Guanghua Xiao, Qinghua Zhou, Adi Gazdar, Yang Xie

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: In the literature, inconsistent associations between the primary locations of lung adenocarcinomas (ADCs) with patient prognosis have been reported, due to varying definitions for central and peripheral locations. In this study, we investigated the clinical characteristics and prognoses of ADCs located in the main bronchus. Methods: A total of 397,189 lung ADCs registered from 2004 to 2013 in the National Cancer Database (NCDB) were extracted and divided into main bronchus-located ADCs (2.5%, N = 10,111) and non-main bronchus ADCs (97.5%, N = 387,078). The ADCs located in the main bronchus and those not in the main bronchus were compared in terms of patient prognosis, lymph node involvement, distant metastases and other clinical features, including rate of curative-intent resection, histologic grade, and stage. Results: ADCs located in the main bronchus had significantly worse patient survival than those in the non-main bronchus, both for all patients (HR = 1.82, 95% CI 1.78–1.86) and for those undergoing curative-intent resection (HR = 2.49, 95% CI 2.23–2.78). Furthermore, ADCs located in the main bronchus had a significantly higher rate of lymph node involvement and distant metastasis than those not in the main bronchus, when stratified by tumor size (trend test, p < e−16). Multivariate analysis of overall survival showed that main bronchus location is a prognostic factor (HR = 1.15, 95% CI 1.08–1.23) independent of other clinical factors. Conclusions: Main bronchus location is an independent predictor for metastasis and worse outcomes irrespective of stage and treatment. Tumor primary location might be considered in prognostication and treatment planning.

Original languageEnglish (US)
Pages (from-to)22-26
Number of pages5
JournalLung Cancer
Volume120
DOIs
StatePublished - Jun 1 2018

Fingerprint

Bronchi
Cohort Studies
Neoplasm Metastasis
Adenocarcinoma
Adenocarcinoma of lung
Lymph Nodes
Neoplasms
Survival
Multivariate Analysis
Databases

Keywords

  • Lung adenocarcinoma
  • Main bronchus
  • Patient prognosis
  • Surgery
  • The National Cancer Database
  • Tumor location

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma : A large cohort analysis. / Yang, Lin; Wang, Shidan; Gerber, David E.; Zhou, Yunyun; Xu, Feng; Liu, Jiewei; Liang, Hao; Xiao, Guanghua; Zhou, Qinghua; Gazdar, Adi; Xie, Yang.

In: Lung Cancer, Vol. 120, 01.06.2018, p. 22-26.

Research output: Contribution to journalArticle

Yang, Lin ; Wang, Shidan ; Gerber, David E. ; Zhou, Yunyun ; Xu, Feng ; Liu, Jiewei ; Liang, Hao ; Xiao, Guanghua ; Zhou, Qinghua ; Gazdar, Adi ; Xie, Yang. / Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma : A large cohort analysis. In: Lung Cancer. 2018 ; Vol. 120. pp. 22-26.
@article{1d1aed0c9c294e12a943f12e55f28bed,
title = "Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma: A large cohort analysis",
abstract = "Objectives: In the literature, inconsistent associations between the primary locations of lung adenocarcinomas (ADCs) with patient prognosis have been reported, due to varying definitions for central and peripheral locations. In this study, we investigated the clinical characteristics and prognoses of ADCs located in the main bronchus. Methods: A total of 397,189 lung ADCs registered from 2004 to 2013 in the National Cancer Database (NCDB) were extracted and divided into main bronchus-located ADCs (2.5{\%}, N = 10,111) and non-main bronchus ADCs (97.5{\%}, N = 387,078). The ADCs located in the main bronchus and those not in the main bronchus were compared in terms of patient prognosis, lymph node involvement, distant metastases and other clinical features, including rate of curative-intent resection, histologic grade, and stage. Results: ADCs located in the main bronchus had significantly worse patient survival than those in the non-main bronchus, both for all patients (HR = 1.82, 95{\%} CI 1.78–1.86) and for those undergoing curative-intent resection (HR = 2.49, 95{\%} CI 2.23–2.78). Furthermore, ADCs located in the main bronchus had a significantly higher rate of lymph node involvement and distant metastasis than those not in the main bronchus, when stratified by tumor size (trend test, p < e−16). Multivariate analysis of overall survival showed that main bronchus location is a prognostic factor (HR = 1.15, 95{\%} CI 1.08–1.23) independent of other clinical factors. Conclusions: Main bronchus location is an independent predictor for metastasis and worse outcomes irrespective of stage and treatment. Tumor primary location might be considered in prognostication and treatment planning.",
keywords = "Lung adenocarcinoma, Main bronchus, Patient prognosis, Surgery, The National Cancer Database, Tumor location",
author = "Lin Yang and Shidan Wang and Gerber, {David E.} and Yunyun Zhou and Feng Xu and Jiewei Liu and Hao Liang and Guanghua Xiao and Qinghua Zhou and Adi Gazdar and Yang Xie",
year = "2018",
month = "6",
day = "1",
doi = "10.1016/j.lungcan.2018.03.011",
language = "English (US)",
volume = "120",
pages = "22--26",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Main bronchus location is a predictor for metastasis and prognosis in lung adenocarcinoma

T2 - A large cohort analysis

AU - Yang, Lin

AU - Wang, Shidan

AU - Gerber, David E.

AU - Zhou, Yunyun

AU - Xu, Feng

AU - Liu, Jiewei

AU - Liang, Hao

AU - Xiao, Guanghua

AU - Zhou, Qinghua

AU - Gazdar, Adi

AU - Xie, Yang

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Objectives: In the literature, inconsistent associations between the primary locations of lung adenocarcinomas (ADCs) with patient prognosis have been reported, due to varying definitions for central and peripheral locations. In this study, we investigated the clinical characteristics and prognoses of ADCs located in the main bronchus. Methods: A total of 397,189 lung ADCs registered from 2004 to 2013 in the National Cancer Database (NCDB) were extracted and divided into main bronchus-located ADCs (2.5%, N = 10,111) and non-main bronchus ADCs (97.5%, N = 387,078). The ADCs located in the main bronchus and those not in the main bronchus were compared in terms of patient prognosis, lymph node involvement, distant metastases and other clinical features, including rate of curative-intent resection, histologic grade, and stage. Results: ADCs located in the main bronchus had significantly worse patient survival than those in the non-main bronchus, both for all patients (HR = 1.82, 95% CI 1.78–1.86) and for those undergoing curative-intent resection (HR = 2.49, 95% CI 2.23–2.78). Furthermore, ADCs located in the main bronchus had a significantly higher rate of lymph node involvement and distant metastasis than those not in the main bronchus, when stratified by tumor size (trend test, p < e−16). Multivariate analysis of overall survival showed that main bronchus location is a prognostic factor (HR = 1.15, 95% CI 1.08–1.23) independent of other clinical factors. Conclusions: Main bronchus location is an independent predictor for metastasis and worse outcomes irrespective of stage and treatment. Tumor primary location might be considered in prognostication and treatment planning.

AB - Objectives: In the literature, inconsistent associations between the primary locations of lung adenocarcinomas (ADCs) with patient prognosis have been reported, due to varying definitions for central and peripheral locations. In this study, we investigated the clinical characteristics and prognoses of ADCs located in the main bronchus. Methods: A total of 397,189 lung ADCs registered from 2004 to 2013 in the National Cancer Database (NCDB) were extracted and divided into main bronchus-located ADCs (2.5%, N = 10,111) and non-main bronchus ADCs (97.5%, N = 387,078). The ADCs located in the main bronchus and those not in the main bronchus were compared in terms of patient prognosis, lymph node involvement, distant metastases and other clinical features, including rate of curative-intent resection, histologic grade, and stage. Results: ADCs located in the main bronchus had significantly worse patient survival than those in the non-main bronchus, both for all patients (HR = 1.82, 95% CI 1.78–1.86) and for those undergoing curative-intent resection (HR = 2.49, 95% CI 2.23–2.78). Furthermore, ADCs located in the main bronchus had a significantly higher rate of lymph node involvement and distant metastasis than those not in the main bronchus, when stratified by tumor size (trend test, p < e−16). Multivariate analysis of overall survival showed that main bronchus location is a prognostic factor (HR = 1.15, 95% CI 1.08–1.23) independent of other clinical factors. Conclusions: Main bronchus location is an independent predictor for metastasis and worse outcomes irrespective of stage and treatment. Tumor primary location might be considered in prognostication and treatment planning.

KW - Lung adenocarcinoma

KW - Main bronchus

KW - Patient prognosis

KW - Surgery

KW - The National Cancer Database

KW - Tumor location

UR - http://www.scopus.com/inward/record.url?scp=85044478516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044478516&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2018.03.011

DO - 10.1016/j.lungcan.2018.03.011

M3 - Article

C2 - 29748011

AN - SCOPUS:85044478516

VL - 120

SP - 22

EP - 26

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

ER -